Image -
ALP-2301-1,Ejvind Mortz.jpg
Mass spectrometry-based analysis of biologics will soon have its own chapter in the US Pharmacopeia. MS analysis delivers significantly more detailed and informative data than today’s most widely used methods and marks a breakthrough that could revolutionize impurity control in the drug industry. Photo: Alphalyse A/S
go to media item
- License:
- Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format:
- .jpg
- Size:
- 2000 x 3006, 909 KB
